C
Cuu Long Pharmaceutical JSC
VN:DCL
Cuu Long Pharmaceutical JSC
VN:DCL
Price:
37 150
VND
-6.89%
Market Closed
Market Cap:
₫2.7T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
VN |
|
Compagnie du Bois Sauvage SA
XBRU:COMB
|
BE |
|
Limes Schlosskliniken AG
XETRA:LIK
|
DE |
|
Y
|
Yubo International Biotech Ltd
OTC:YBGJ
|
CN |
|
Toho Zinc Co Ltd
TSE:5707
|
JP |
|
Wagners Holding Company Ltd
ASX:WGN
|
AU |
|
TechTarget Inc
NASDAQ:TTGT
|
US |
|
Melrose Industries PLC
LSE:MRO
|
UK |
|
D
|
Deutsch Motors Inc
KOSDAQ:067990
|
KR |
|
City Union Bank Ltd
BSE:532210
|
IN |
Multiples-Based Value
The Multiples-Based Value for Cuu Long Pharmaceutical JSC (DCL) under the Base Case is hidden VND. Compared with the current market price of 37 150 VND, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DCL Multiples-Based Value
LOCKED
Multiples Across Competitors
DCL Competitors Multiples
Cuu Long Pharmaceutical JSC Competitors
Cuu Long Pharmaceutical JSC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| VN |
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
2.7T VND | 2.1 | 139 | 28.2 | 53.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 5.9 | 26.8 | 17.2 | 22 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.5B GBP | 5.2 | 29.8 | 16.5 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.2 | 12.5 | 16.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.1 | 8.2 | 9.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.5B GBP | 2.6 | 15.1 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
